Company Performance: Abeona Therapeutics' financial health, including revenue, profitability, and pipeline progress, directly impacts investor confidence and stock price.

Clinical Trial Results: Positive or negative outcomes from clinical trials of Abeona's gene and cell therapies significantly influence the stock's value due to the high-risk, high-reward nature of biotechnology.

Regulatory Approvals: Approval or rejection of Abeona's therapies by regulatory bodies like the FDA or EMA heavily affects investor sentiment and the stock price.

Market Conditions: Overall market trends, investor sentiment, and economic factors can influence the demand for and price of ABEA.XETRA.

Competition: Activities of competing companies in the gene and cell therapy space, including their clinical trial results and regulatory approvals, can affect Abeona's perceived market position and stock value.

Industry News: General news and trends within the biotechnology and gene therapy industries can impact investor perception of Abeona and its stock price.

Financing Activities: Announcements regarding fundraising, such as stock offerings or debt financing, can influence the stock price due to potential dilution of existing shares.

Mergers and Acquisitions: Rumors or actual mergers and acquisitions involving Abeona or other companies in the sector can lead to significant price fluctuations.

Analyst Ratings: Recommendations and price targets issued by financial analysts can influence investor decisions and affect the stock's price.

Geopolitical Events: Global events, political instability, and changes in government regulations can indirectly influence market sentiment and the price of ABEA.XETRA.